Xeris Pharmaceuticals(DE:2B30)
€13.96+0.09 (+0.61%)
DE:2B30
Xeris Pharmaceuticals earnings date
€13.96
At close:+0.09 (+0.61%)
Xeris Pharmaceuticals (2B30) Q1 2023 Earnings Report
0 Followers
DE:2B30 Q1 2023 EPS Results
- Actual EPS
- -EUR 0.11
- Consensus EPS
- -EUR 0.14
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.22
DE:2B30 Q1 2023 Revenue Results
- Actual Revenue
- EUR 29.72M
- Expected Revenue
- EUR 27.79M
- Beat/Miss
- Beat by +EUR 1.94M
- YoY Revenue Growth
- +50.39%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/09/2023
- Time
- Before Open
- Conference Call
- Tuesday, May 9, 2023
DE:2B30 Upcoming Earnings
Xeris Pharmaceuticals's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
DE:2B30 Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2B30 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | 0.06- | 0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.030.05 | 0 | ― | |
| Aug 06, 2026 | 2026 (Q2) | 0.01-0.16 | -0.01 | -1700.00% (-0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.000.01 | -0.05 | 116.67% (+0.06) | |
| Mar 02, 2026 | 2025 (Q4) | 0.020.05 | -0.03 | 300.00% (+0.08) | |
| Nov 06, 2025 | 2025 (Q3) | 0.010.00 | -0.1 | 100.00% (+0.10) | |
| Aug 07, 2025 | 2025 (Q2) | -0.03-0.01 | -0.09 | 90.00% (+0.08) | |
| May 08, 2025 | 2025 (Q1) | -0.04-0.05 | -0.13 | 57.14% (+0.07) | |
| Mar 06, 2025 | 2024 (Q4) | -0.05-0.03 | -0.09 | 70.00% (+0.06) | |
| Nov 08, 2024 | 2024 (Q3) | -0.08-0.10 | -0.08 | -22.22% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
